305 results on '"Nanto S"'
Search Results
2. Poster session Thursday 12 December - PM: 12/12/2013, 14: 00–18: 00Location: Poster area
3. Characteristics of peripheral arterial disease in Japanese type 2 diabetic patients
4. Variation during the week in the incidence of acute myocardial infarction: increased risk for Japanese women on Saturdays
5. Abstract No. 93 - Impact of chronic renal failure on safety and effectiveness of paclitaxel-eluting stents for femoropopliteal artery disease: 24-month results from the Zilver PTX Japan Post-Market Surveillance Study
6. Abstract No. 92 - Effectiveness of the Zilver PTX drug-eluting stent for femoropopliteal peripheral arterial disease in patients with no tibial runoff vessels: 24-month results from the Zilver PTX Post-Market Study in Japan
7. Inducible atrial tachycardias with multiple circuits in a stepwise approach are associated with increased episodes of atrial tachycardias after catheter ablation.
8. Regional cerebral oxygen saturation on hospital arrival is a potential novel predictor of neurological outcomes at hospital discharge in patients with out-of-hospital cardiac arrest.
9. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents.
10. Mechanism of impaired left ventricular wall motion in the diabetic heart without coronary artery disease.
11. Effects of coronary angioplasty on left ventricular diastolic filling in patients with old myocardial infarction: A study with pulsed Doppler echocardiography.
12. Elastic recoil and intimal thickening after coronary stenting.
13. Role of atrial contraction and synchrony of ventricular contraction in the optimisation of ventriculoarterial coupling in humans.
14. A case of hypertensive-diabetic cardiomyopathy demonstrating left ventricular wall motion abnormality.
15. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials.
16. Relation of C-reactive protein and one-year survival after acute myocardial infarction with versus without statin therapy.
17. Impact of high-sensitivity C-reactive protein on predicting long-term mortality of acute myocardial infarction.
18. Examination of cardiac production of nitric oxide in patients with chronic heart failure
19. Quantitative relationship between coronary microvascular damage and myocardial viability assessed by doppler guidewire
20. The effect of percutaneous transluminal coronary angioplasty on syntheses of thromboxane A 2 and prostacyclin in coronary circulation
21. Coronary flow and myocardial metabolism during ischemic attack: Effort angina vs variant angina
22. Metabolic changes in hibernating myocardium after percutaneous transluminal coronary angioplasty and the relation between recovery in left ventricular function and free fatty acid metabolism.
23. Impact of 12-Month Angioscopic Thrombi and Yellow Plaque After Drug-Eluting Stent Implantation.
24. Consensus statement on renal denervation by the Joint Committee of Japanese Society of Hypertension (JSH), Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT), and the Japanese Circulation Society (JCS).
25. Impact of baseline yellow plaque assessed by coronary angioscopy on vascular response after stent implantation.
26. Clinical Outcomes of Transradial vs Nontransradial Aortoiliac Endovascular Therapy.
27. Anti-hypertensive medication adherence in the REQUIRE trial: post-hoc exploratory evaluation.
28. Technical aspects should also be fully considered in order to obtain better effectiveness of RDN.
29. Type II Kounis syndrome diagnosed by optical coherence tomography and coronary angioscopy.
30. Healing process of myocardial edema in acute perimyocarditis: Observation by speckle-tracking echocardiography and cardiac magnetic resonance parametric mapping.
31. Comparison of 1-Month and 12-Month Vessel Responses Between the Polymer-Free Biolimus A9-Coated Stent and the Durable Polymer Everolimus-Eluting Stent.
32. Clinical Impact of Intravascular Ultrasound-Guided Fluoropolymer-Based Drug-Eluting Stent Implantation for Femoropopliteal Lesions.
33. 1-Year Outcomes of Fluoropolymer-Based Drug-Eluting Stent in Femoropopliteal Practice: Predictors of Restenosis and Aneurysmal Degeneration.
34. Clinical Impact of Measures for Frailty Severity in Poor-Risk Patients Undergoing Revascularization for Chronic Limb-Threatening Ischemia.
35. Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial.
36. Effects of renal denervation on blood pressures in patients with hypertension: a systematic review and meta-analysis of randomized sham-controlled trials.
37. Renal denervation: basic and clinical evidence.
38. Novel Image of Neovascularization on Optical Coherence Tomography Confirmed by Coronary Angioscopy.
39. Renal Artery Fibromuscular Dysplasia Observed on Nonobstructive Angioscopy.
40. Axitinib-related cardiac dysfunction occurring after resumption of treatment.
41. Angioscopic Findings of Neovascularization Around Yellow Plaque.
42. Blood Pressure Level and Variability During Long-Term Prasugrel or Clopidogrel Medication After Stroke: PRASTRO-I.
43. Long-Term Effectiveness of a Drug-Eluting Stent for Femoropopliteal In-Stent Restenosis: Subanalysis of the Zilver PTX Japan Post-Market Surveillance Study.
44. One-Year Outcomes of Heparin-Bonded Stent-Graft Therapy for Real-World Femoropopliteal Lesions and the Association of Patency With the Prothrombotic State Based on the Prospective, Observational, Multicenter V i a bahn Ste n t-Graft Placement for Femoropopliteal Diseases Re qui ring Endova s cular T h erapy (VANQUISH) Study.
45. Efficacy and Safety of Prasugrel by Stroke Subtype: A Sub-Analysis of the PRASTRO-I Randomized Controlled Trial.
46. Cardiac pseudomass due to enlarged epicardial adipose tissue: Comparison of echocardiography and cardiac magnetic resonance imaging.
47. Impact of different coronary angioscopic findings on arterial healing one year after bioresorbable-polymer and second-generation durable-polymer drug-eluting stent implantation.
48. Distribution of Paclitaxel Particles After Drug-Coated Balloon Treatment - Comparison Between Intravascular Ultrasound Images and Electronic High-Resolution Angioscopy.
49. Distribution of Paclitaxel Particles on the Vascular Wall After Drug-Coated Balloon Treatment - Electronic High-Resolution Angioscopy Assessment.
50. Paclitaxel Particle Distribution 3 Months After Drug-Coated Balloon Treatment - Zemporshe ® Angioscopy Assessment.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.